Comparative Effectiveness Study Telerehab Versus Conventional
Primary Purpose
Multiple Sclerosis
Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Exercise program for people with MS
Sponsored by
About this trial
This is an interventional supportive care trial for Multiple Sclerosis focused on measuring Multiple sclerosis, Exercise, Physical activity, Telerehabilitation, Comparative effectiveness study, Social cognitive theory, Health behavior change
Eligibility Criteria
Inclusion Criteria:
- Mild to moderate MS
- Has limitations in walking but can walk 25 feet
- Does not participate in a rigorous exercise program
- Can travel to trial site for assessments and training
Exclusion Criteria:
- Relapse in the past 30 days
- Other neurological or musculoskeletal disorders
Sites / Locations
- The Tanner Center for Multiple Sclerosis
- University of Alabama
- University of Colorado
- University of Georgia
- Shepherd Center
- Massachusetts General Hospital
- University of North Carolina
- Cleveland Clinic
- Marquette University
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Facility-based rehabilitation
Telerehabilitation
Arm Description
Participants will conduct the exercise program for people with MS in a facility, for example a gym, or rehabilitation center. They will receive coaching on site at the facility.
Participants will conduct the exercise program for people with MS at home and receive coaching via phone or Skype sessions.
Outcomes
Primary Outcome Measures
Timed 25 Foot Walk Test (T25FWT)
Measure of walking speed
Secondary Outcome Measures
Six Minute Walk Test
Measures walking endurance
Multiple Sclerosis Walking Scale-12 questionnaire
Measures the impact of MS on walking ability and daily activities over the past two weeks
Godin Leisure-Time questionnaire
7-day recall of leisure-time physical activity to determine individual's activity level
Quality of Life in Neurological Disorders (Neuro-QOL) survey
A validated outcome measure of quality of life
Unidimensional Fatigue Impact Score
A self-report measure of fatigue in people with MS. The total score for the MFIS is the sum of the scores for the 22 items and can range from 0 to 88. Higher scores indicate a greater impact of fatigue on a person's activities.
Multiple Sclerosis Impact Scale-29
Measures individual's views on the impact of MS on day-to-day life during the past two weeks. It has two subscales: a 20-item physical impact scale and a 9-item psychological impact scale (and no total score). Scores on the physical impact scale can range from 20 to 80 and on the psychological impact scale from 9 to 36, with lower scores indicating little impact of MS and higher scores indicating greater impact.
Modified Fatigue Impact Scale
Measures impact of fatigue on the participant's activities and lifestyle over the past four weeks. The total score for the MFIS is the sum of the scores for the 21 items and can range from 0 to 84. Higher scores indicate a greater impact of fatigue on a person's activities.
Social Cognitive Theory (SCT)
A battery of measures to measure the core SCT constructs of self-efficacy, outcome expectations, goal setting, self-monitoring, overcoming barriers, perceived social support.
Expanded Disability Status Scale
Characterizes disability level and determines disability progression in people with MS. The EDSS scale ranges from 0 to 10 in 0.5 unit increments that represent higher levels of disability (0 equals low).
Patient Determined Disease Steps
Patient reported measure of disability in MS. The scale ranges from 0 to 8.
Full Information
NCT ID
NCT03468868
First Posted
March 6, 2018
Last Updated
July 31, 2023
Sponsor
Shepherd Center, Atlanta GA
Collaborators
University of Alabama at Birmingham, University of North Carolina, Chapel Hill, University of Georgia, The Cleveland Clinic, University of Colorado, Denver, Marquette University, Accelerated Cure Project for Multiple Sclerosis, Patient-Centered Outcomes Research Institute, Tanner Foundation for Multiple Sclerosis, Massachusetts General Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03468868
Brief Title
Comparative Effectiveness Study Telerehab Versus Conventional
Official Title
Comparative Effectiveness Study of an Exercise Intervention Delivered Via Telerehabilitation and Conventional Mode of Delivery
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
July 23, 2018 (Actual)
Primary Completion Date
December 30, 2023 (Anticipated)
Study Completion Date
August 31, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Shepherd Center, Atlanta GA
Collaborators
University of Alabama at Birmingham, University of North Carolina, Chapel Hill, University of Georgia, The Cleveland Clinic, University of Colorado, Denver, Marquette University, Accelerated Cure Project for Multiple Sclerosis, Patient-Centered Outcomes Research Institute, Tanner Foundation for Multiple Sclerosis, Massachusetts General Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study aims to compare the effectiveness of an exercise program delivered in a conventional facility-based format versus a telerehabilitation format, which takes place in the home. Exercise can improve mobility and perhaps decrease the rate and extent of disability in people with MS. Evidence shows that traditional, facility-based exercise training may help people with MS consistently participate in exercise or to exercise at a higher, more intense level. Despite this evidence, lack of access to facility-based exercise programs may make it difficult for people with MS to engage in exercise.Telerehabilitation (telerehab) has great potential to overcome challenges associated with facility-based programs. Telerehab can include videoconferencing, remote monitoring of signs and activity, and dissemination of specialized and individualized information via electronic mechanisms, such as smartphones and computers. Both facility-based and telerehab exercise training have yielded positive results in people with MS, but have not been compared head-to-head. The current study will fill this gap in the evidence base and compare the outcomes of delivering the same exercise interventions in a facility or in the home/community using a telerehab approach. The interventions are designed to be identical in content, with the only difference being the mode of training delivery.
Detailed Description
Funded by Patient-Centered Outcomes Research Institute (PCORI), this four-year, multi-site study aims to compare the effectiveness of a 16-week telerehabilitation (telerehab) exercise program and a facility-based exercise program on Multiple Sclerosis (MS) outcomes. The research study design is a two-stage randomized choice design aimed at non-inferiority.
Four hundred participants with MS who have ambulatory difficulties will be recruited from nine sites. First level randomization will assign participants to one of two groups - Choice or Random. The participants in Choice will be able to choose in which program they wish to participate (telerehab or facility-based). Individuals in the Random group, will be further randomized to either the telerehab or facility-based program. The research protocol and associated tools will be reviewed and approved by all relevant Research Review Committees before any research takes place. The study will comply with best practices in human subjects' research including following HIPAA guidelines and using strict informed consent procedures. Clinical reported outcome measures and patient reported outcome measures will be administered at baseline, immediately post-intervention (at 16 weeks), and at 12 months post-intervention. Patient reported outcomes will also be administered at 2 months and 6 months after the start of the intervention.
Dr. Deborah Backus is the principal investigator (PI) and Prof. Robert Motl is the co-Principal Investigator supported by collaborating co-Investigators at the Cleveland Clinic Mellen Center, Ohio; Marquette University, Wisconsin; University of Colorado, Denver; University of North Carolina, Chapel Hill; the University of Georgia; the Tanner Center for Multiple Sclerosis, Birmingham Alabama; Massachusetts General Hospital, Boston, Massachusetts; and the iConquerMS outcomes data collaborative (Accelerated Cure Project for MS). Shepherd Center is the primary and coordinating site for all study activities under Dr. Backus. University of Alabama at Birmingham (UAB) under the leadership of Prof. Motl will oversee delivery of the training programs, and statistical analysis under the direction of Dr. Gary Cutter.
This study will yield important data regarding the comparative impact of exercise programs on MS outcomes and provide information to people with MS, health providers, payers, exercise partners, and policy makers about how people with MS who have ambulatory difficulties can safely and effectively exercise.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Sclerosis
Keywords
Multiple sclerosis, Exercise, Physical activity, Telerehabilitation, Comparative effectiveness study, Social cognitive theory, Health behavior change
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Two-stage randomized choice design aimed at noninferiority.
Masking
Outcomes Assessor
Masking Description
Evaluators who assess clinical reported outcomes will be blinded to arm assignment.
Allocation
Randomized
Enrollment
400 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Facility-based rehabilitation
Arm Type
Active Comparator
Arm Description
Participants will conduct the exercise program for people with MS in a facility, for example a gym, or rehabilitation center. They will receive coaching on site at the facility.
Arm Title
Telerehabilitation
Arm Type
Active Comparator
Arm Description
Participants will conduct the exercise program for people with MS at home and receive coaching via phone or Skype sessions.
Intervention Type
Behavioral
Intervention Name(s)
Exercise program for people with MS
Intervention Description
The intervention consists of 30 minutes of resistance training and 30 minutes of cardio three times per week for 16 weeks.
Primary Outcome Measure Information:
Title
Timed 25 Foot Walk Test (T25FWT)
Description
Measure of walking speed
Time Frame
Change from baseline T25FWT at 16-weeks and at 12 months post intervention
Secondary Outcome Measure Information:
Title
Six Minute Walk Test
Description
Measures walking endurance
Time Frame
Change from baseline at 16 weeks and 12 months post intervention
Title
Multiple Sclerosis Walking Scale-12 questionnaire
Description
Measures the impact of MS on walking ability and daily activities over the past two weeks
Time Frame
Change from baseline at 8 weeks, at 16 weeks, at 6 months post intervention, and at 12 months post intervention
Title
Godin Leisure-Time questionnaire
Description
7-day recall of leisure-time physical activity to determine individual's activity level
Time Frame
Change from baseline at 8 weeks, at 16 weeks, at 6 months post intervention, and at 12 months post intervention
Title
Quality of Life in Neurological Disorders (Neuro-QOL) survey
Description
A validated outcome measure of quality of life
Time Frame
Change from baseline at 8 weeks, at 16 weeks, at 6 months post intervention, and at 12 months post intervention
Title
Unidimensional Fatigue Impact Score
Description
A self-report measure of fatigue in people with MS. The total score for the MFIS is the sum of the scores for the 22 items and can range from 0 to 88. Higher scores indicate a greater impact of fatigue on a person's activities.
Time Frame
Change from baseline at 8 weeks, at 16 weeks, at 6 months post intervention, and at 12 months post intervention
Title
Multiple Sclerosis Impact Scale-29
Description
Measures individual's views on the impact of MS on day-to-day life during the past two weeks. It has two subscales: a 20-item physical impact scale and a 9-item psychological impact scale (and no total score). Scores on the physical impact scale can range from 20 to 80 and on the psychological impact scale from 9 to 36, with lower scores indicating little impact of MS and higher scores indicating greater impact.
Time Frame
Change from baseline at 8 weeks, at 16 weeks, at 6 months post intervention, and at 12 months post intervention
Title
Modified Fatigue Impact Scale
Description
Measures impact of fatigue on the participant's activities and lifestyle over the past four weeks. The total score for the MFIS is the sum of the scores for the 21 items and can range from 0 to 84. Higher scores indicate a greater impact of fatigue on a person's activities.
Time Frame
Change from baseline at 8 weeks, at 16 weeks, at 6 months post intervention, and at 12 months post intervention
Title
Social Cognitive Theory (SCT)
Description
A battery of measures to measure the core SCT constructs of self-efficacy, outcome expectations, goal setting, self-monitoring, overcoming barriers, perceived social support.
Time Frame
Change from baseline at 8 weeks, at 16 weeks, at 6 months post intervention, and at 12 months post intervention
Title
Expanded Disability Status Scale
Description
Characterizes disability level and determines disability progression in people with MS. The EDSS scale ranges from 0 to 10 in 0.5 unit increments that represent higher levels of disability (0 equals low).
Time Frame
Change from baseline at 16 weeks and 12 months post intervention
Title
Patient Determined Disease Steps
Description
Patient reported measure of disability in MS. The scale ranges from 0 to 8.
Time Frame
Change from baseline at 16 weeks and 12 months post intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Mild to moderate MS
Has limitations in walking but can walk 25 feet
Does not participate in a rigorous exercise program
Can travel to trial site for assessments and training
Exclusion Criteria:
Relapse in the past 30 days
Other neurological or musculoskeletal disorders
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Deborah Backus, PT, PhD
Organizational Affiliation
Shepherd Center, Atlanta GA
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Tanner Center for Multiple Sclerosis
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35209
Country
United States
Facility Name
University of Alabama
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35209
Country
United States
Facility Name
University of Colorado
City
Denver
State/Province
Colorado
ZIP/Postal Code
80045
Country
United States
Facility Name
University of Georgia
City
Athens
State/Province
Georgia
ZIP/Postal Code
30602
Country
United States
Facility Name
Shepherd Center
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30309
Country
United States
Facility Name
Massachusetts General Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02114
Country
United States
Facility Name
University of North Carolina
City
Raleigh
State/Province
North Carolina
ZIP/Postal Code
27599
Country
United States
Facility Name
Cleveland Clinic
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States
Facility Name
Marquette University
City
Milwaukee
State/Province
Wisconsin
ZIP/Postal Code
53233
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Comparative Effectiveness Study Telerehab Versus Conventional
We'll reach out to this number within 24 hrs